aTyr Pharma (FRA:471A) FCF Yield % : -34.22 (As of May. 06, 2024)

View and export this data going back to 2016. Start your Free Trial

What is aTyr Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, aTyr Pharma's Trailing 12-Month Free Cash Flow is €-34.65 Mil, and Market Cap is €101.95 Mil. Therefore, aTyr Pharma's FCF Yield % for today is -34.22%.

The historical rank and industry rank for aTyr Pharma's FCF Yield % or its related term are showing as below:

FRA:471A' s FCF Yield % Range Over the Past 10 Years
Min: -234.27 Med: -43.13 Max: -14.8
Current: -34.22

During the past 11 years, the highest FCF Yield % of aTyr Pharma was -14.80%. The lowest was -234.27%. And the median was -43.13%.

FRA:471A's FCF Yield % is ranked worse than
68.58% of 1553 companies
in the Biotechnology industry
Industry Median: -14.39 vs FRA:471A: -34.22

aTyr Pharma's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

aTyr Pharma FCF Yield % Historical Data

The historical data trend for aTyr Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aTyr Pharma FCF Yield % Chart

aTyr Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-121.63

-35.69

-16.68

-72.70

-42.05

aTyr Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-76.75	-6.79	-49.33	-44.35	-49.78

Competitive Comparison of aTyr Pharma's FCF Yield %

For the Biotechnology subindustry, aTyr Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

aTyr Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, aTyr Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where aTyr Pharma's FCF Yield % falls into.

aTyr Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

aTyr Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-34.329	/	81.639456
	=	-42.05%

aTyr Pharma's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-10.16	*	4	/	81.639456
	=	-49.78%

aTyr Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

aTyr Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of aTyr Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

aTyr Pharma (FRA:471A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » aTyr Pharma Inc (FRA:471A) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

LIFE:USA

Address

10240 Sorrento Valley Road, Suite 300, San Diego, CA, USA, 92121

Website

https://www.atyrpharma.com

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

aTyr Pharma (FRA:471A) Headlines

No Headlines